Benzinga | Feb 22, 2021 09:31AM EST

Morgan Stanley Maintains Overweight on NICE, Raises Price Target to $338

Morgan Stanley maintains NICE (NASDAQ:NICE) with a Overweight and raises the price target from $334 to $338.